Women Health
If your practice compounds or administers non-commercial formulations, now is the time for a legal compliance check-up.
E.RedlineS.AzarbarzinA.et al (2024)
Despite the limited number of targets and the emergence of resistance, which pose challenges for antifungal therapy, new drugs such as Ibrexafungerp (formerly known as SCY-078), Rezafungin, Fosmanogepix and Olorofim have shown promising clinical efficacy (Wiederhold, 2020
Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J, Mattheus M, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF